|
"jia horng kao"的相關文件
顯示項目 901-950 / 1180 (共24頁)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T09:14:10Z |
Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load.
|
Chen, Ding-Shinn; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng; Tseng, Tai-Chung;Liu, Chun-Jen;Yang, Hung-Chih;Su, Tung-Hung;Wang, Chia-Chi;Chen, Chi-Ling;Kuo, Stephanie Fang-Tzu;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;劉俊人 ;陳培哲 ;陳祈玲; Tseng, Tai-Chung; Tseng, Tai-Chung; CHUN-JEN LIU; Liu, Chun-Jen; PEI-JER CHEN; Liu, Chun-Jen; Yang, Hung-Chih; Yang, Hung-Chih; CHEN-HUA LIU; TUNG-HUNG SU; Su, Tung-Hung; Su, Tung-Hung; Wang, Chia-Chi; DING-SHINN CHEN; Wang, Chia-Chi; JIA-HORNG KAO; Chen, Chi-Ling; Kuo, Stephanie Fang-Tzu; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Pei-Jer |
| 臺大學術典藏 |
2018-09-10T09:14:10Z |
Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin.
|
Yu, Ming-Lung; Liu, Chen-Hua; Huang, Chung-Feng; Tseng, Tai-Chung; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Kao, Jia-Horng; Re, Valli De; CHEN-HUA LIU; Yu, Ming-Lung; Liu, Chen-Hua; JIA-HORNG KAO; Liu, Chen-Hua; Huang, Chung-Feng; Tseng, Tai-Chung; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Kao, Jia-Horng; Kao, Jia-Horng; RE, Valli DE |
| 臺大學術典藏 |
2018-09-10T09:13:59Z |
Association of hepatitis C virus infection and malnutrition-inflammation complex syndrome in maintenance hemodialysis patients
|
Tsai, H.-B. and Chen, P.-C. and Liu, C.-H. and Hung, P.-H. and Chen, M.-T. and Chiang, C.-K. and Kao, J.-H. and Hung, K.-Y.; Tsai, Hung-Bin;Chen, Pau-Chung;Liu, Chen-Hua;Hung, Peir-Haur;Chen, Mei-Tsu;Chiang, Chih-Kang;Kao, Jia-Horng;Hung, Kuan-Yu; 劉振驊 ;高嘉宏 ;陳保中 ;姜至剛 ;洪冠予; CHIH-KANG CHIANG; Tsai, Hung-Bin; Pau-Chung CHEN; Chen, Pau-Chung; Liu, Chen-Hua; HUNG-BIN TSAI; Hung, Peir-Haur; CHEN-HUA LIU; JIA-HORNG KAO; Chen, Mei-Tsu; KUAN-YU HUNG; Chiang, Chih-Kang; Kao, Jia-Horng; Hung, Kuan-Yu |
| 臺大學術典藏 |
2018-09-10T08:44:46Z |
Uncovered issues in the overview of nonalcoholic steatohepatitis
|
Wang, Chia-Chi;Kao, Jia-Horng; JIA-HORNG KAO; WANG, CHIA-CHI; KAO, JIA-HORNG; Chang, Hao-Hueng |
| 臺大學術典藏 |
2018-09-10T08:44:45Z |
Recent advances in the treatment of chronic hepatitis B
|
Lin, C.-L. ;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:44:44Z |
HBV/A and HBV/C genotype predominance among patients with chronic hepatitis B virus infection in Cebu City, Philippines
|
Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; 陳定信; 劉振驊; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 曾岱宗;高嘉宏; Batoctoy, K.S. and Tseng, T.-C. and Kao, J.-H. and Quiza, F.E. and Garcia Sr., L.H. and Lao-Tan, J.; Batoctoy, Karen S.; Tseng, Tai-Chung; Kao, Jia-Horng; Quiza, Fidelis E.; Garcia, Lamberto H.; Lao-Tan, Judy; Cheng, Huei-Ru; JIA-HORNG KAO; Kao, Jia-Horng; Batoctoy, Karen S.; Wu, Hui-Lin; Tseng, Tai-Chung; Liu, Chen-Hua; Kao, Jia-Horng; Yang, Hung-Chih; Lao-Tan, Judy; Quiza, Fidelis E.; Su, Tung-Hung; Garcia, Lamberto H. |
| 臺大學術典藏 |
2018-09-10T08:44:44Z |
Hepatitis C virus and lipid profiles: More questions than answers?
|
Hsu, Ching-Sheng;Kao, Jia-Horng; HSU, CHING-SHENG;KAO, JIA-HORNG; 許景盛;高嘉宏; JIA-HORNG KAO; Hsu, Ching-Sheng; Liu, Wei-Liang; HSU, CHING-SHENG; Chao, You-Chen; KAO, JIA-HORNG; Lin, Hans Hsienhong; Tseng, Tai-Chung; Wang, Chia-Chi; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信 |
| 臺大學術典藏 |
2018-09-10T08:44:44Z |
Hepatitis during antituberculosis treatment
|
Wu, Li-Wei; Kao, Jia-Horng; JIA-HORNG KAO; Wu, Li-Wei; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T08:44:44Z |
Il-28b predicts response to chronic hepatitis C therapy -fine-mapping and replication study in Asian populations
|
Ochi, H.; Maekawa, T.; Abe, H. ;Hayashida, Y.; Nakano, R.; Imamura, M. ;Hiraga, N. ;Kawakami, Y. ;Aimitsu, S.; Kao, J.H. ;Tsunoda, M.K.; Tsunoda, T.; Kumada, H.; Nakamura, Y.; Hayes, N.C. ;Chayama, K.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:44:43Z |
Boceprevir for chronic HCV genotype 1 infection [2]
|
Hsu, C.-S. ;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:44:43Z |
Entecavir: A review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease
|
Keating, G.M.; Buti, M.; Gadano, A. ;Kao, J.-H. ;Lee, C.-M.; Peng, C.-Y.; Schiff, E.R.; Tanwandee, T.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:44:32Z |
Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses
|
Yeh, M.-L.; Hung, C.-H.; Huang, J.-F.; Liu, C.-J.; Lee, C.-M.; Dai, C.-Y.; Wang, J.-H.; Lin, Z.-Y.; Lu, S.-N.; Hu, T.-H.; Yu, M.-L.; Kao, J.-H.; Chuang, W.-L.; Chen, P.-J.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:44:32Z |
Reply to Guedj et al.: Early transient increase of hepatitis C virus viral load in genotype 1 and 2 infections, and the use of mathematical modeling
|
Hsu, Ching-Sheng;Jeng, Jenher;Kao, Jia-Horng;Chen, Ding-Shinn; DING-SHINN CHEN; JIA-HORNG KAO; HSU, CHING-SHENG; JENG, JENHER; KAO, JIA-HORNG; CHEN, DING-SHINN |
| 臺大學術典藏 |
2018-09-10T08:41:24Z |
Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: Genotype B vs C
|
Liu, C.-J. ;Cheng, H.-R.; Chen, C.-L.; Chen, T.-C.; Tseng, T.-C.; Wang, Z.-L. ;Chen, P.-J. ;Liu, C.-H. ;Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:38:36Z |
Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients
|
Liu, C.-H. ;Liang, C.-C. ;Huang, K.-W.; Liu, C.-J. ;Chen, S.-I.; Lin, J.-W. ;Hung, P.-H.; Tsai, H.-B. ;Lai, M.-Y. ;Chen, P.-J. ;Chen, J.-H. ;Chen, D.-S. ;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; HUNG-BIN TSAI; CHEN-HUA LIU; DING-SHINN CHEN; KAI-WEN HUANG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:31:55Z |
Aboriginal Taiwanese hepatitis B carriers have more favorable viral factors than Han Chinese carriers
|
Nien, Hsiao-Ching;Sheu, Jin-Chuan;Kao, Jia-Horng;Chou, Huei-Chi;Su, Chien-Wen;Chen, Chien-Hung; JIN-CHUAN SHEU; JIA-HORNG KAO; NIEN, HSIAO-CHING; SHEU, JIN-CHUAN; KAO, JIA-HORNG; CHOU, HUEI-CHI; SU, CHIEN-WEN; CHEN, CHIEN-HUNG |
| 臺大學術典藏 |
2018-09-10T08:31:41Z |
Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy
|
Tseng, T.-C. ;Yu, M.-L.; Liu, C.-J.; Lin, C.-L. ;Huang, Y.-W.; Hsu, C.-S.; Liu, C.-H.; Kuo, S.F.-T. ;Pan, C.J.-H. ;Yang, S.-S. ;Su, C.-W. ;Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; YI-WEN HUANG; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:13Z |
Treatment of hepatitis C virus infection in patients with end-stage renal disease
|
Liu, C.-H.;Kao, J.-H.; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:08Z |
Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy.
|
Chun-Jen Liu;Pei-Jer Chen;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:08Z |
Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy.
|
Chun-Jen Liu;Pei-Jer Chen;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:08Z |
HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection.
|
Chun-Jen Liu;Pei-Jer Chen;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:08Z |
HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection.
|
Chun-Jen Liu;Pei-Jer Chen;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:07Z |
Interleukin-28B genetic variations and response to interferon-based therapy: Asian perspectives.
|
Chen-Hua Liu;Jia-Horng Kao; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:07Z |
Interleukin-28B genetic variations and response to interferon-based therapy: Asian perspectives.
|
Chen-Hua Liu;Jia-Horng Kao; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:07Z |
Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan.
|
Chun-Jen Liu;Pei-Jer Chen;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:30:07Z |
Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan.
|
Chun-Jen Liu;Pei-Jer Chen;Chen-Hua Liu;Ding-Shinn Chen;Jia-Horng Kao; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:28:55Z |
Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load
|
Wang, J.-Y.;Liu, C.-H.;Hu, F.-C.;Chang, H.-C.;Liu, J.-L.;Chen, J.-M.;Yu, C.-J.;Lee, L.-N.;Kao, J.-H.;Yang, P.-C.; LI-NA LEE; Chong-Jen Yu; JANN-YUAN WANG; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:50Z |
Rifaximin treatment in hepatic encephalopathy [1]
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:50Z |
Role of Viral Factors in Modifying Weight-Related Effects on Disease Progression of Chronic Hepatitis C Patients
|
Hsu, C.;Kao, J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:50Z |
Treatment of chronic hepatitis B in Asia-Pacific countries: Is the Asia-Pacific consensus statement being followed?
|
Sung, J.J.Y.;Amarapurkar, D.;Chan, H.L.Y.;Cheng, J.;Kao, J.-H.;Han, K.-H.;Piratvisuth, T.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:50Z |
Use of statins and gallstone risk [1]
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:50Z |
慢性丙型肝炎治疗的新进展：从病毒到宿主
|
許景盛;高嘉宏; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Intrathecal delivery of a mutant μ-opioid receptor activated by naloxone as a possible antinociceptive paradigm
|
Kao, J.H.;Chen, S.L.;Ma, H.I.;Law, P.Y.;Tao, P.L.;Loh, H.H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Letter to the editor
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Metformin improves sustained virologic response in difficult-to-cure hepatitis c: More questions than answers
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Optimal management of hepatocellular carcinoma: Challenges and opportunities
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Outcomes of HCV treatment: Who does well and who does not?
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:49Z |
Preoperative drainage in pancreatic cancer
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Clinical implications of hepatitis B virus variants
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy
|
Lui, Y.Y.-N.;Tsoi, K.K.-F.;Wong, V.W.-S.;Kao, J.-H.;Hou, J.-L.;Teo, E.-K.;Mohamed, R.;Piratvisuth, T.;Han, K.-H.;Mihm, U.;Wong, G.L.-H.;Chan, H.L.-Y.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
From liver markers to life expectancy
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Hepatitis B e antigen seroconversion: A critical event in chronic hepatitis B virus Infection
|
Liaw, Yun-Fan; Lau, George K. K.; Kao, Jia-Horng; Gane, Edward; JIA-HORNG KAO; Liaw, Yun-Fan; Lau, George K. K.; Kao, Jia-Horng; Gane, Edward |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Hepatitis C infection and metabolic syndrome.
|
JIA-HORNG KAO; Hsu, C.S.;Kao, J.H. |
| 臺大學術典藏 |
2018-09-10T08:16:48Z |
Hepatitis C virus infection, lipids, and coronary heart disease: A Pandora's box
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan
|
Huang, Y.-W.;Liao, Y.-T.;Chen, W.;Chen, C.-L.;Hu, J.-T.;Liu, C.-J.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Yang, S.-S.;Kao, J.-H.; CHUN-JEN LIU; YI-WEN HUANG; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection
|
Tong, Myron John; Hsu, Leeyen; Hsien, Carlos; Kao, Jia-Horng; Durazo, Francisco Antonio; Saab, Sammy; Blatt, Lawrence Mitchell; JIA-HORNG KAO; Tong, Myron John; Hsu, Leeyen; Hsien, Carlos; Kao, Jia-Horng; Durazo, Francisco Antonio; Saab, Sammy; Blatt, Lawrence Mitchell |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
A novel antibody associated with autoimmune pancreatitis [4]
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
Alanine aminotransferase, metabolic syndrome, and cardiovascular disease: A missing link
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:47Z |
Carvedilol versus variceal band ligation for prevention of the first variceal bleed
|
Wang, C.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:16:46Z |
Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B
|
Huang, Y.-W.;Chayama, K.;Tsuge, M.;Takahashi, S.;Hatakeyama, T.;Abe, H.;Hu, J.-T.;Liu, C.-J.;Lai, M.-Y.;Chen, D.-S.;Yang, S.-S.;Kao, J.-H.; CHUN-JEN LIU; YI-WEN HUANG; DING-SHINN CHEN; JIA-HORNG KAO |
顯示項目 901-950 / 1180 (共24頁)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
每頁顯示[10|25|50]項目
|
